Hillsdale Investment Management Inc. Nevro Corp Transaction History

Hillsdale Investment Management Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 09, 2021	SELL	$138.17 - $184.34 $1.02 Million - $1.36 Million	-7,400 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$114.09 - $145.51 $159,726 - $203,714	1,400 Added 23.33%	7,400 $1.03 Million
Q2 2020 Aug 11, 2020	SELL	$89.45 - $129.85 $2.17 Million - $3.16 Million	-24,300 Reduced 80.2%	6,000 $717,000
Q1 2020 May 12, 2020	BUY	$70.23 - $144.31 $2.13 Million - $4.37 Million	30,300 New	30,300 $3.03 Million

151

39.3M

67.9K

1.59M

Ticker NVRO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 35,387,800
Market Cap $133M
Description
Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...

Get notified when there are updates to the investment portfolio of Hillsdale Investment Management Inc., based on Form 13F filings with the SEC.

Stay updated on Hillsdale Investment Management Inc. with notifications on news.